» Articles » PMID: 25765319

Epigenetic Mechanisms of Chronic Pain

Overview
Journal Trends Neurosci
Specialty Neurology
Date 2015 Mar 14
PMID 25765319
Citations 151
Authors
Affiliations
Soon will be listed here.
Abstract

Neuropathic and inflammatory pain promote a large number of persisting adaptations at the cellular and molecular level, allowing even transient tissue or nerve damage to elicit changes in cells that contribute to the development of chronic pain and associated symptoms. There is evidence that injury-induced changes in chromatin structure drive stable changes in gene expression and neural function, which may cause several symptoms, including allodynia, hyperalgesia, anxiety, and depression. Recent findings on epigenetic changes in the spinal cord and brain during chronic pain may guide fundamental advances in new treatments. Here, we provide a brief overview of epigenetic regulation in the nervous system and then discuss the still-limited literature that directly implicates epigenetic modifications in chronic pain syndromes.

Citing Articles

Electroacupuncture produces analgesic effects via cannabinoid CB1 receptor-mediated GABAergic neuronal inhibition in the rostral ventromedial medulla.

Wan K, Xu Q, Shi Y, Cui C, Lei J, Zhang K Chin Med. 2025; 20(1):30.

PMID: 40038719 PMC: 11881457. DOI: 10.1186/s13020-025-01083-4.


Differential DNA methylation profiles of Alzheimer's disease-related genomic pathways in the blood of cognitively-intact individuals with and without high impact chronic pain.

Strath L, Meng L, Zhang Y, Rani A, Huo Z, Foster T J Alzheimers Dis Rep. 2025; 8(1):1549-1557.

PMID: 40034342 PMC: 11863755. DOI: 10.1177/25424823241289376.


Therapeutic approach to fibromyalgia: a consensus statement on pharmacological and non-pharmacological treatment from the neuropathic pain special interest group of the Italian neurological society.

Devigili G, Di Stefano G, Donadio V, Frattale I, Grazzi L, Mantovani E Neurol Sci. 2025; .

PMID: 39982626 DOI: 10.1007/s10072-025-08048-3.


Innovations in acute and chronic pain biomarkers: enhancing diagnosis and personalized therapy.

Mackey S, Aghaeepour N, Gaudilliere B, Kao M, Kaptan M, Lannon E Reg Anesth Pain Med. 2025; 50(2):110-120.

PMID: 39909549 PMC: 11877092. DOI: 10.1136/rapm-2024-106030.


Biosynthesis inhibition of miR-142-5p in a N-methyladenosine-dependent manner induces neuropathic pain through CDK5/TRPV1 signaling.

Li J, Guo Y, Zhu C, Wang D, Li Y, Hao X Cell Mol Biol Lett. 2025; 30(1):16.

PMID: 39891095 PMC: 11786349. DOI: 10.1186/s11658-025-00695-w.


References
1.
Cordeiro-Silva M, Oliveira Z, Vasconcelos de Podesta J, Gouvea S, von Zeidler S, Louro I . Methylation analysis of cancer-related genes in non-neoplastic cells from patients with oral squamous cell carcinoma. Mol Biol Rep. 2011; 38(8):5435-41. DOI: 10.1007/s11033-011-0698-1. View

2.
Imai S, Saeki M, Yanase M, Horiuchi H, Abe M, Narita M . Change in microRNAs associated with neuronal adaptive responses in the nucleus accumbens under neuropathic pain. J Neurosci. 2011; 31(43):15294-9. PMC: 6703523. DOI: 10.1523/JNEUROSCI.0921-11.2011. View

3.
Cherng C, Lee K, Chien C, Chou K, Cheng Y, Hsin S . Baicalin ameliorates neuropathic pain by suppressing HDAC1 expression in the spinal cord of spinal nerve ligation rats. J Formos Med Assoc. 2013; 113(8):513-20. DOI: 10.1016/j.jfma.2013.04.007. View

4.
Fuks F, Hurd P, Wolf D, Nan X, Bird A, Kouzarides T . The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem. 2002; 278(6):4035-40. DOI: 10.1074/jbc.M210256200. View

5.
Dekker F, van den Bosch T, Martin N . Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases. Drug Discov Today. 2013; 19(5):654-60. DOI: 10.1016/j.drudis.2013.11.012. View